Clinical Trials Directory

Trials / Unknown

UnknownNCT00525967

Switching From Morphine to Oral Methadone Plus Acetaminophen in the Treatment of Cancer Pain

Switching From Morphine to Oral Methadone Plus Acetaminophen in the Treatment of Cancer Pain: A Randomized, Double-Blind Study

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Faculdade de Medicina do ABC · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether oral methadone plus acetaminophen can substitute morphine in the treatment of cancer pain.

Detailed description

Opioids are the mainstay of moderate-to-severe cancer pain management. Although morphine is the most commonly used, methadone has some advantages such as higher potency, lower cost and longer administration intervals. To minimize the time necessary to achieve the equianalgesic effect after a switching from morphine to methadone, acetaminophen was added in the treatment.

Conditions

Interventions

TypeNameDescription
DRUGMethadone plus Acetaminophen or PlaceboMethadone bid according to a established conversion morphine-to-methadone ratio plus Placebo or Acetaminophen qid

Timeline

Start date
2006-02-01
Completion
2007-10-01
First posted
2007-09-06
Last updated
2007-09-06

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT00525967. Inclusion in this directory is not an endorsement.